What BioWise Technologies Inc. does

BioWise Technologies Inc. is a privately-held Canadian biotechnology company founded in 2024 and headquartered in Ottawa, Ontario, that develops fungal protein ingredients for sustainable pet nutrition using an advanced fermentation platform. The company applies specially selected mushroom and fungal strains in a controlled fermentation process to produce high-purity (99.9%) protein ingredients with documented advantages in yield, consistency, and environmental footprint versus conventional animal protein sources.

Its core product portfolio centers on the FungiPro ingredient line — FungiPro 70 (a 70%-protein fungal flour) and FungiPro 85 (an 85%-protein isolate) — supplemented by Custom Formulations services that tailor protein specifications and technical support to individual customer requirements. Underlying the products is a proprietary platform that combines novel strain identification, high-throughput microbial screening with data-driven parameter optimization, and bioprocessing capabilities designed for 100x scale-up from lab to industrial production.

BioWise operates a B2B go-to-market targeting pet food manufacturers seeking sustainable, hypoallergenic protein alternatives. Commercialization is anchored on a December 2025 strategic partnership with an unnamed leading pet food manufacturer for premium hypoallergenic dog food, with first products expected on shelves 18-24 months after quality testing and regulatory approvals. The company's revenue model combines ingredient sales with professional-services-style custom formulation work, supported by content marketing, an investor relations portal, and industry partnerships; the company is pre-revenue as of the most recent disclosed information, with capital to date limited to the January 2026 Invest Ottawa Ignition Grant.

Name

BioWise Technologies Inc.

Legal name

BioWise Technologies Inc.

Website

https://biowisetech.ca

Company type

Private

Founded year

2024

Operating status

Operating

Short description

BioWise Technologies Inc., founded in 2024 in Ottawa, Canada, develops proprietary fungal protein ingredients (FungiPro 70 and 85) via advanced fermentation for B2B pet food manufacturers seeking sustainable, hypoallergenic protein alternatives. The company is pre-revenue and is commercializing through a strategic partnership with a leading pet food manufacturer.

Ownership category

akta.pro rank

Product category

Pet Food Ingredients

NAICS

Animal Food Manufacturing (3111), Dog and Cat Food Manufacturing (311111)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

Alternative Protein & Sustainable Pet Food (insect/plant/cell-based) (CRADAFAI)

akta.pro secondary industries

Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins) (AFAJAHAL), Cultivated (Cell-Based) Protein Foods Manufacturing (AFAKAGAI)

Keywords

• Fungal protein ingredients
• Pet food ingredients
• Alternative protein production
• Fermentation biotechnology
• Sustainable animal nutrition

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Fungal Protein Ingredients: B2B sales of proprietary fungal protein ingredients (FungiPro 70 and FungiPro 85) to pet food manufacturers
2. Custom Formulation Services: Tailored protein solutions designed to meet specific product requirements for pet food manufacturers with technical support

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

BioWise Technologies Inc. develops and produces fungal protein ingredients for the pet food industry using proprietary fermentation technology. The company sells standardized protein ingredients (FungiPro 70 and FungiPro 85) and offers custom formulation services to pet food manufacturers seeking sustainable, high-protein, hypoallergenic alternatives to traditional animal proteins.

Product overview

BioWise Technologies is developing a portfolio of sustainable fungal protein ingredients for the pet food industry, built on their proprietary Advanced Fermentation Platform. The product line includes FungiPro™ 70 (70% protein fungal flour) and FungiPro™ 85 (85% protein isolate) as core protein ingredients, complemented by Custom Formulations for tailored pet food solutions. All products are currently in development and aimed at pet food manufacturers seeking sustainable, hypoallergenic protein alternatives.

Differentiator

Problem solved

Functional benefit

Products and services

• FungiPro 70
• FungiPro 85
• Custom Formulations

Quantifiable outcome

• 90% reduction in water usage compared to conventional animal protein production
• +4 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Leading Pet Food Manufacturer (unnamed)coreStrategic or Co-development Partner · 14 December 2025Strategic partnership with a leading pet food manufacturer to bring BioWise's sustainable fungal protein ingredients to market. BioWise provides proprietary fungal protein ingredients while the partner integrates these into premium pet food formulations. Initial focus is on developing hypoallergenic dog food products meeting growing consumer demand for sustainable and healthy pet nutrition. First products expected to reach shelves within 18-24 months following quality testing and regulatory approvals.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• The EVERY Company: The EVERY Company uses precision fermentation to produce animal-free proteins such as egg and whey, with the same underlying technology stack as BioWise and growing adjacency into pet food formulations.
• Nature's Fynd: Nature's Fynd uses fungal fermentation to produce nutritional protein (Fy) primarily for human food. It shares BioWise's core fermentation platform and fungal-strain moat but currently focuses on a different end market, making it a tech peer rather than a direct competitor.

Direct peers

• Wild Earth: Wild Earth develops fungal- and plant-based protein for pet food and treats, sharing BioWise's microbial-protein-for-pet-food positioning and targeting the same sustainable, clean-label consumer segment.
• Because Animals: Because Animals develops cultivated (cell-based) meat ingredients for pet food, directly overlapping BioWise in the alternative-protein-for-pet-nutrition category with a similar B2B ingredient play.
• Bond Pet Foods: Bond Pet Foods uses precision fermentation to produce animal-free meat proteins specifically for pet food applications - the same B2B ingredient model and end market as BioWise, making it the closest direct competitor.

Broad incumbents

• Open Farm: Open Farm is a premium pet food brand built around sustainable, high-protein sourcing. It sits on the demand side of BioWise's value chain and represents the type of partner BioWise could supply with fungal protein ingredients.
• Quorn: Quorn is the established mycoprotein (fungal fermentation) brand for human food and is a relevant broad incumbent demonstrating commercial scale-up of fungal protein, signaling the commercial trajectory BioWise is targeting in pet food.
• Mars Petcare: Mars Petcare is one of the two global pet food majors and has launched alternative-protein initiatives. It competes for shelf space and partnerships with BioWise, while also being a credible potential scale partner.
• Nestlé Purina: Purina is the world's largest pet food manufacturer and an explicit 'leading pet food manufacturer' archetype relevant to BioWise's strategic partnership; it also pursues sustainable protein initiatives, making it both a potential customer and a broad competitive incumbent.
• Cargill: Cargill is a major animal nutrition and pet food ingredient supplier with growing exposure to alternative proteins. It overlaps with BioWise in protein ingredient sourcing and supply to pet food manufacturers, albeit at materially larger scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioWise Technologies Inc.